References
- Leslie R DG, Atkinson M A, Notkins A. L. Autoantigens IA-2A and GAD in Type 1 (insulin-dependent) diabetes. Diabetologia 1999; 42: 3–14
- Lernmark Å. Type 1 Diabetes. Clin Chem 1999; 45(8(B))1331–1338
- Christie M R, Genovese S, Cassidy D, Bosi E, Brown T J, Lai M, et al. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 1994; 43: 1254–1259
- Whittingham S, Byron S L, Tuomilehto J, Zimmet P. Z., Myers M A, Vidgren G, et al. Autoantibodies associated with pre-symptomatic insulin-dependent diabetes mellitus in women. Diabet Med 1997; 678–685
- Marshall M O, Hoyer P E, Petersen J S, Hajnaes K R, Genovese S, Dyrbcrg T, et al. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J Autoimmunity 1994; 7: 497–508
- de Seissler J., Sonnaville J JJ, Morgenthaler N, Steinbrenner G. H, Glawe D, Khoo-Morgcnthaler U Y, et al. Immunological heterogeneity in Type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 1998; 41: 891–897
- Sabbah E, Savola K, Kulmala P., Veijola R, Vahiisalo P, Kar-Jalainen J, et al. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type I diabetes. J Clin Endocrinol Metab 1999; 84: 1534–1539
- World Health Organization Technical Report Series No 727. Diabetes Mellitus: Report of a WHO Study Group. WHO, Geneva 1985
- Östman J., Arnqvist H, Blohmé G., Lithner F, Littorin B, Nystrom L, et al. Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15–34 years. Acta Med Scand 1986; 220: 437–445
- Landin-Olsson M, Sundkvisl G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence lest increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327–332
- Verge C F, Stenger D, Bonifacio E, Colman P G, Pitcher C, Bingley P J, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type I diabetes. Diabetes 1998; 47: 1857–1866
- Grubin C E, Daniels T, Toivola B, Landin-Olsson M, Hagopian W A, Li L, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Duibeto-logia 1994; 37: 344–350
- Falorni A, Örtqvist E, Persson B, Lernmark Å. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Method 1995; 186: 89–99
- Gianani R, Rabin D U, Verge C F, Liping Yu, Babu S, Pie-Tropaolo R. M, et al. ICA512 autoantibody radioassay. Diabetes 1995; 44: 1340–1344
- Törn C, Landin-Olsson M, Scherstén B. Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients. Practical Diabetes International, In press
- Ludvigsson J, Hellström S. Autoantibodies in relation to residual insulin secretion in children with IDDM. Diabetes Res Clin Pract 1997; 35: 81–89
- Kulmala P, Savola K, Petersen J S, Vähäsalo P., Karjalainen J, Löppönen T, et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. J Clin Invest 1998; 101: 327–336
- Zimmet P Z, Tuomi T, Mackay I R, Rowley M J, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994; 22: 53–58